Welcome to Vero Consulting LLC. Navigating the path from biological discovery to clinical application is the most critical challenge in drug development. I provide expert strategic consulting for pharmaceutical and biotech companies, leveraging over a decade of leadership experience in translational medicine at Genentech.. My mission is to help you design and execute robust, data-driven translational and biomarker strategies that accelerate your programs, mitigate risk, and deliver transformative medicines to patients.
My name is Dr. Veronica Anania. For more than 10 years, I have been at the forefront of translational science in the biotech industry, leading teams and initiatives to translate complex biological insights into clinical impact.
As a Director and Senior Principal Scientist in Translational Medicine at Genentech, I led numerous cross-functional teams, guiding molecules from candidate nomination through pivotal clinical development and initial registration. A key achievement was establishing the Translational Medicine Mass Spectrometry Clinical Proteomics Laboratory from the ground up, creating a world-class facility to discover decision-enabling biomarkers for clinical programs.
My work has spanned dozens of clinical studies across Neuroscience, Immunology, and Rare Diseases. I have a proven track record of authoring biomarker sections for global BLA filings, presenting strategies to governance committees, and fostering collaborations with academic and industry partners to drive innovation.
I hold a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley, and a B.S. from the University of California, Santa Cruz. Now, through Vero Consulting, I offer my deep strategic and scientific expertise to help your organization achieve its drug development goals.
I offer comprehensive consulting services tailored to the unique needs of your drug development programs. My expertise is focused on creating and implementing actionable strategies that yield clear, interpretable results for informed decision-making.
Is your team facing a complex translational challenge? Are you looking to build a robust biomarker strategy to de-risk your clinical program and accelerate your timeline?
I am eager to learn about your specific needs and discuss how my experience can directly benefit your organization25. Reach out to begin the conversation.
Email: veronica@veroconsultingllc.com
LinkedIn: https://www.linkedin.com/in/veronica-anania-phd
